Minami Omura
Overview
Explore the profile of Minami Omura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Omura M, Kosaka T, Kobayashi H, Shigeta K, Matsumoto K, Hara S, et al.
Ann Surg Oncol
. 2024 Apr;
31(6):3914-3915.
PMID: 38564070
No abstract available.
2.
Omura M, Kosaka T, Kobayashi H, Shigeta K, Matsumoto K, Hara S, et al.
Ann Surg Oncol
. 2024 Feb;
31(5):2951-2958.
PMID: 38376711
Background And Purpose: Neoadjuvant chemotherapy (NAC) is a well-established standard practice in invasive bladder cancer (BCa), however patient selection remains challenging. High expression of vasohibin-1 (VASH1), an endogenous regulator of...
3.
Shigeta K, Matsumoto K, Kitaoka S, Omura M, Umeda K, Arita Y, et al.
Eur Urol Oncol
. 2024 Feb;
7(6):1338-1349.
PMID: 38320909
Background: Although several studies have shown favorable outcomes in upper tract urothelial carcinoma (UTUC) with fibroblast growth factor receptor 3 (FGFR3) mutations and/or expression, the relationship between immune cell markers...
4.
Omura M, Kikuchi E, Shigeta K, Ogihara K, Hakozaki K, Hara S, et al.
Jpn J Clin Oncol
. 2022 Feb;
52(4):388-396.
PMID: 35106598
Background: Although the administration of neoadjuvant chemotherapy has been associated with improved prognosis in patients with muscle-invasive bladder cancer, the therapeutic effects of adjuvant chemotherapy remain unknown in real-world settings....
5.
Omura M, Kosaka T, Aimono E, Nakamura K, Hongo H, Mikami S, et al.
IJU Case Rep
. 2022 Jan;
5(1):41-44.
PMID: 35005470
Introduction: Deoxyribonucleic acid repair gene mutations are now being studied in a variety of solid tumors, with the hope of predicting prognosis, pathogenesis, and treatment outcomes. Case Presentation: We report...
6.
Matsumoto K, Omura M, Takeda T, Kosaka T, Hashiguchi A, Takamatsu K, et al.
J Urol
. 2021 Apr;
206(2):338-345.
PMID: 33818138
Purpose: In general, the index lesion of prostate cancer has the largest tumor volume, the highest Grade Group (GG), and the highest stage (concordant cases). However, these factors sometimes do...
7.
Kamisawa K, Ohigashi T, Omura M, Takamatsu K, Matsui Z
J Endourol Case Rep
. 2020 Oct;
6(3):150-152.
PMID: 33102713
Ureterosciatic hernia (USH) is a rare benign disease. We report a case of USH treated with laparoscopic intraperitonization of the ureter. A 70-year-old woman was admitted to our hospital with...
8.
Takamatsu K, Mizuno R, Omura M, Morita S, Matsumoto K, Shinoda K, et al.
Clin Genitourin Cancer
. 2018 Apr;
16(4):e927-e933.
PMID: 29678472
Background: Almost half of patients with metastatic renal-cell carcinoma (mRCC) are classified as intermediate risk by the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) model. The aim of this...
9.
Niwa N, Matsumoto K, Miyahara M, Omura M, Kobayashi H, Kikuchi E, et al.
World J Urol
. 2017 Feb;
35(9):1455-1461.
PMID: 28220189
Purpose: To develop practical nomograms for predicting the stone-free rate after shock wave lithotripsy (SWL) in patients with a solitary stone in the proximal ureter. Methods: Between July 2006 and...